Bigul

Outcome/Results Of The Meeting Of The Board Of Directors Of The Company Held On 10Th November, 2017

Dear Sir, This is to inform you that the Board of Directors of the Company, in their meeting held on 10th November, 2017 (which concluded at 5.55 p.m.), have inter-alia considered and approved the Standalone Un-audited Financial Results of the Company, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and Half-year ended 30th September, 2017, along with Limited Review Report thereon (Copy enclosed)....
10-11-2017
Bigul

Outcome of Board Meeting

Dear Sir, This is to inform you that the Board of Directors of the Company, in their meeting held on 10th November, 2017 (which concluded at 5.55 p.m.), have inter-alia considered and approved the Standalone Un-audited Financial Results of the Company, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and Half-year ended 30th September, 2017, along with Limited Review Report thereon (Copy enclosed)....
10-11-2017
Bigul

Morepen Labs inks pact with Belgian firm Vesale Pharma

Morepen Laboratories today said it has signed an agreement with Belgian firm Vesale Pharma to strengthen its presence in the probiotics segment. The tie up will expand Morepen's formulations...
09-11-2017
Bigul

Clarifies on News Item

With reference to news appeared in www.business-standrad.com dated November 09, 2017 quoting "Morepen to partner Belgian firm for probiotic products", Morepen Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.
09-11-2017
Bigul

Press Release / Media Release

Dear Sir, Please find enclosed the disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 and Press Release on the agreement for an exclusive distribution and marketing tie-up between Morepen Laboratories Limited and Vesale Pharma of Belgium, which was signed yesterday late evening at Hotel Taj Palace, in the esteemed presence of the King and the Queen of Belgium who are on their State visit to India. Kindly acknowledge the receipt and take it on record.
09-11-2017
Bigul

Memorandum of Understanding /Agreements

Dear Sir, Please find enclosed the disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 and Press Release on the agreement for an exclusive distribution and marketing tie-up between Morepen Laboratories Limited and Vesale Pharma of Belgium, which was signed yesterday late evening at Hotel Taj Palace, in the esteemed presence of the King and the Queen of Belgium who are on their State visit to India. Kindly acknowledge the receipt and take it on record.
09-11-2017
Bigul

Clarification sought from Morepen Laboratories Ltd

The Exchange has sought clarification from Morepen Laboratories Ltd on November 09, 2017, with reference to news appeared in www.business-standrad.com dated November 9, 2017 quoting "Morepen to partner Belgian firm for probiotic products"The reply is awaited.
09-11-2017
Bigul

Closure of Trading Window

Dear Sir, Notice is hereby given, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of Board of Directors of the Company is scheduled to be held on Friday, 10th November, 2017, inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter and Half-year ended 30th September, 2017....
02-11-2017
Bigul

Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On Friday, 10Th November, 2017 And Intimation Of Closure Of Trading Window

Dear Sir, Notice is hereby given, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of Board of Directors of the Company is scheduled to be held on Friday, 10th November, 2017, inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter and Half-year ended 30th September, 2017....
02-11-2017
Bigul

Certificate Pursuant To Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Please find enclosed herewith the certificate from Mr. Praveen Dua, Practising Company Secretary, pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half-year ended 30th September, 2017.
25-10-2017
Next Page
Close

Let's Open Free Demat Account